ISRG down 3.39% pre-market 30 Mar 2026: Intuitive Surgical (NASDAQ) AI view

ISRG stock opened lower pre-market on 30 Mar 2026 after a $15.89 intraday slide to $452.66, reflecting broader market pressure and profit‑taking in high‑multiple healthcare names. We examine how Intuitive Surgical, Inc. (NASDAQ: ISRG) balances robust procedure growth and recurring consumable revenue with a PE of 57.66 and premium valuation. This pre‑market move tests investor patience while AI‑driven robotics narratives keep ISRG stock on many growth investors’ watchlists.

ISRG stock: Price action and short‑term setup

ISRG stock is trading at $452.66, down 3.39% on the session with volume at 2,107,201 versus an average of 1,867,700 shares. The session opened at $465.42 and the intraday range is $451.56–$466.21. Momentum indicators show an RSI of 27.85 (oversold) and MACD histogram at -1.59, signalling short‑term selling exhaustion that could invite mean‑reversion toward the 50‑day average near $505.85 if macro pressure eases.

ISRG stock: Fundamentals and valuation

Intuitive Surgical reported strong revenue growth and beat in the last quarter—EPS $2.53 and revenue $2.87B—but the market prices a premium: trailing EPS is 7.85 and PE is 57.66. Key ratios include price/sales 16.02, price/book 9.04, and free cash flow per share 7.02. The balance sheet is healthy with cash per share 16.72 and debt to equity 0.02, supporting capital allocation but leaving ISRG stock sensitive to execution versus high expectations.

ISRG stock: AI and robotics growth drivers

Intuitive Surgical’s installed base, consumable attach rates and clinical training create durable recurring revenue that benefits from AI‑enabled workflow gains and imaging improvements. Recent institutional buying—Generate Investment Management and Spire Wealth increased positions—supports conviction source source. For AI stock investors, ISRG stock remains a pure‑play robotics exposure in healthcare with system upgrades and digital services as key growth levers.

ISRG stock: Technicals and trading signals

Technical indicators show an oversold profile: CCI -216.55, Williams %R -96.94, and ADX 33.10 indicating a strong downtrend. Bollinger Bands middle is 482.43 with lower band 458.80, implying current price trades below the mid‑band. Short‑term traders may watch support near the $425.00 52‑week low and resistance at the 50‑day average $505.85 for mean‑reversion trades or trend continuation setups.

Meyka AI rates ISRG with a score out of 100 and forecast

Meyka AI rates ISRG with a score out of 100: 79.50 / B+ — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of $585.45, a quarterly target of $485.77, and a monthly near‑term figure of $438.35. Compared with the current price $452.66, the yearly projection implies an upside of 29.33%. Forecasts are model‑based projections and not guarantees. Our reporting uses Meyka AI as an AI‑powered market analysis platform to frame risks and opportunities for ISRG stock.

ISRG stock: Risks and catalysts

Main risks include high valuation sensitivity (PE 57.66), execution on system placements and consumable growth, and macro shocks that compress multiples. Catalysts that could re-rate ISRG stock include faster adoption of Ion and da Vinci upgrades, better than expected procedure growth, and sustained margin expansion. Insider selling is noted—insiders sold 32,943 shares valued at $17,279,568 in the last quarter—and should be monitored alongside institutional buying trends.

Final Thoughts

Key takeaways for ISRG stock: Intuitive Surgical trades at $452.66 on NASDAQ in the United States after a pre‑market down move, reflecting short‑term risk off despite healthy fundamentals. The company posted an EPS beat and revenue growth, but the stock carries a premium multiple (PE 57.66) that makes it sensitive to execution and macro headlines. Meyka AI’s forecast model projects a $585.45 12‑month level, implying 29.33% upside from today’s price; this assumes continued system adoption, recurring consumable demand, and modest margin improvement. For AI stocks investors, ISRG stock remains a core pure‑play on surgical robotics and workflow automation, but position sizing should reflect elevated valuation and volatility. Use technical levels—support near $425.00 and resistance near $505.85—to manage entries and exits. Remember, Meyka AI grades and forecasts inform analysis but are not investment advice; conduct your own due diligence and consider portfolio fit with risk tolerance.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.